ArticleJournal of translational medicine2026
POSTN⁺ CAF-SPP1⁺ macrophage crosstalk is associated with immune exclusion and poor prognosis in lung adenocarcinoma.
Article in Journal of translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundLung adenocarcinoma (LUAD) is a highly lethal malignancy in which the tumor microenvironment (TME) plays an important role in disease progression and therapeutic resistance. However, the spatial organization and molecular basis of stromal-immune interactions in LUAD remain incompletely understood.
methodsWe integrated bulk RNA sequencing, single-cell RNA sequencing, spatial transcriptomics, multiplex immunofluorescence, and in vitro functional assays to characterize TME heterogeneity and investigate mechanisms associated with stromal barrier formation and immune exclusion in LUAD.
resultsPOSTN⁺ cancer-associated fibroblasts (CAFs) and SPP1⁺ macrophages were enriched in LUAD, showed marked spatial colocalization, and were associated with an immune-excluded spatial pattern characterized by limited effector T-cell infiltration. Cell-cell communication analysis identified SPP1-centered signaling from SPP1⁺ macrophages to POSTN⁺ CAFs, with CD44 emerging as a prominent receptor candidate and integrin-related receptor pairs suggested as additional candidate branches. In vitro experiments showed that TAM-like macrophage-conditioned medium activated CAF-like HFL-1 cells, increased POSTN, FN1, and COL1A1 expression, enhanced fibroblast adhesion and collagen gel contraction, and restricted primary CD8⁺ T-cell migration across CAF-like stromal barriers. These effects were attenuated by SPP1 neutralization or CD44 knockdown. In addition, CAF-derived C3 was implicated in a feedback loop that may reinforce the SPP1⁺/CD206⁺ macrophage-like phenotype. Pan-cancer analyses further showed that this stromal-myeloid program was conserved across multiple solid tumor types and was associated with poor overall survival, while exploratory cross-cancer immunotherapy analysis suggested a potential association with reduced response to immune checkpoint blockade.
conclusionThese findings further define a spatially organized POSTN⁺ CAF-SPP1⁺ macrophage niche that may contribute to stromal remodeling, CD8⁺ T-cell exclusion, and potentially reduced immunotherapy benefit in LUAD. The TAM-derived SPP1-CD44 axis and CAF-derived C3 feedback loop may provide a framework for biomarker development and therapeutic targeting in immune-excluded solid tumors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.